|
|
News Breaks
|
November 12, 2009
|
| 10:02 EDT |  | CBST |
| theflyonthewall.com: | Cubist Pharma options active on renewed takeover chatter | | Cubist Pharmaceuticals is recently up 40c to $17.84 on renewed takeover chatter. Cubist Pharmaceuticals Cubicin is the first antibiotic in a new class of anti-infective called lipopeptides. CBST November option implied volatility is at 56, November is at 47, January is at 49; verses its 26-week average of 51. CBST November 17.5 calls have traded 90 times on transaction volume of 2,968 contracts, above its open interest 808 contracts according to Track Data, suggesting traders positioning for price movement. :theflyonthewall.com |
|
|
News For CBST From The Last 14 Days Check below for free stories on CBST the last two weeks.
There is 1 item on the Fly with pertinent information.
Sign up for a free trial to see the rest of the stories you've been missing. |
|
February 9, 2012
|
| 07:02 EDT |  | CBST |
| theflyonthewall.com: | Cubist receives CUBICIN Paragraph IV notice letter | | Cubist Pharmaceuticals announced that it has received a Paragraph IV Notice Letter from Hospira advising of the filing of an Abbreviated New Drug Application for a generic version of CUBICIN. :theflyonthewall.com |
|
|
|
|
|
